|
1
|
Drenthen LCA, Roerink SHPP, Mattijssen V
and de Boer H: Bilaterally enlarged adrenal glands without obvious
cause: Need for a multidisciplinary diagnostic work-up. Clin Case
Rep. 6:729–734. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mohan DR, Lerario AM and Hammer GD:
Therapeutic targets for adrenocortical carcinoma in the genomics
era. J Endocr Soc. 2:1259–1274. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paragliola RM, Torino F, Papi G, Locantore
P, Pontecorvi A and Corsello SM: Role of mitotane in adrenocortical
carcinoma-review and state of the art. Eur Endocrinol. 14:62–66.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fragni M, Fiorentini C, Rossini E, Fisogni
S, Vezzoli S, Bonini SA, Dalmiglio C, Grisanti S, Tiberio GAM,
Claps M, et al: In vitro antitumor activity of progesterone in
human adrenocortical carcinoma. Endocrine. 63:592–601. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Breidbart E, Cameo T, Garvin JH, Hibshoosh
H and Oberfield SE: Pubertal outcome in a female with virilizing
adrenocortical carcinoma. J Pediatr Endocrinol Metab. 29:503–509.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nikoleishvili D, Koberidze G, Kutateladze
M, Zumbadze G and Mariamidze A: Bilateral adrenocortical carcinoma:
Case report and review of literature. Georgian Med News. 19–24.
2018.PubMed/NCBI
|
|
7
|
Stigliano A, Cerquetti L, Lardo P,
Petrangeli E and Toscano V: New insights and future perspectives in
the therapeutic strategy of adrenocortical carcinoma (Review).
Oncol Rep. 37:1301–1311. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Megerle F, Herrmann W, Schloetelburg W,
Ronchi CL, Pulzer A, Quinkler M, Beuschlein F, Hahner S, Kroiss M
and Fassnacht M; German ACC Study Group, : Mitotane monotherapy in
patients with advanced adrenocortical carcinoma. J Clin Endocrinol
Metab. 103:686–1695. 2018. View Article : Google Scholar
|
|
9
|
Oddie PD, Albert BB, Hofman PL, Jefferies
C, Laughton S and Carter PJ: Mitotane in the treatment of childhood
adrenocortical carcinoma: A potent endocrine disruptor. Endocrinol
Diabetes Metab Case Rep 2018. (pii): EDM1800592018.
|
|
10
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin X, Li J, Zhao Q, Feng JR, Gao Q and
Nie JY: WGCNA Reveals Key Roles of IL8 and MMP-9 in progression of
involvement area in colon of patients with ulcerative colitis. Curr
Med Sci. 38:252–258. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wan Q, Tang J, Han Y and Wang D:
Co-expression modules construction by WGCNA and identify potential
prognostic markers of uveal melanoma. Exp Eye Res. 166:13–20. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang Q, Wang R, Wei B, Peng C, Wang L, Hu
G, Kong D and Du C: Candidate biomarkers and molecular mechanism
investigation for glioblastoma multiforme utilizing WGCNA. Biomed
Res Int 2018. 42467032018.
|
|
14
|
Ross JS, Wang K, Rand JV, Gay L, Presta
MJ, Sheehan CE, Ali SM, Elvin JA, Labrecque E, Hiemstra C, et al:
Next-generation sequencing of adrenocortical carcinoma reveals new
routes to targeted therapies. J Clin Pathol. 67:968–973. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Papathomas TG, Duregon E, Korpershoek E,
Restuccia DF, van Marion R, Cappellesso R, Sturm N, Rossi G, Coli
A, Zucchini N, et al: Sarcomatoid adrenocortical carcinoma: A
comprehensive pathological, immunohistochemical, and targeted
next-generation sequencing analysis. Hum Pathol. 58:113–122. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gu Y, Gu W, Dou J, Lu Z, Ba J, Li J, Wang
X, Liu H, Yang G, Guo Q, et al: Diagnostic role of
prostate-specific membrane antigen in adrenocortical carcinoma.
Front Endocrinol (Lausanne). 10:2262019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Romero Arenas MA, Whitsett TG, Aronova A,
Henderson SA, LoBello J, Habra MA, Grubbs EG, Lee JE, Sircar K,
Zarnegar R, et al: Protein expression of PTTG1 as a diagnostic
biomarker in adrenocortical carcinoma. Ann Surg Oncol. 25:801–807.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Duregon E, Volante M, Giorcelli J, Terzolo
M, Lalli E and Papotti M: Diagnostic and prognostic role of
steroidogenic factor 1 in adrenocortical carcinoma: A validation
study focusing on clinical and pathologic correlates. Hum Pathol.
44:822–828. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ding M, Li F, Wang B, Chi G and Liu H: A
comprehensive analysis of WGCNA and serum metabolomics manifests
the lung cancer-associated disordered glucose metabolism. J Cell
Biochem. 120:10855–10863. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng S, Cherniack AD, Dewal N, Moffitt
RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA,
Ciriello G, et al: Comprehensive pan-genomic characterization of
adrenocortical carcinoma. Cancer cell. 29:723–736. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gentleman RC, Carey VJ, Bates DM, Bolstad
B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al:
Bioconductor: Open software development for computational biology
and bioinformatics. 5:R802004.PubMed/NCBI
|
|
23
|
Colaprico A, Silva TC, Olsen C, Garofano
L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM,
Castiglioni I, et al: TCGAbiolinks: An R/Bioconductor package for
integrative analysis of TCGA data. Nucleic Acids Res. 44:e712016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Team RC, R, . A language and environment
for statistical computing. 2013.
|
|
25
|
Shi H, Zhang L, Qu Y, Hou L, Wang L and
Zheng M: Prognostic genes of breast cancer revealed by gene
co-expression network analysis. Oncol Lett. 14:4535–4542. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng F, Desai RJ, Handy DE, Wang R,
Schneeweiss S, Barabási AL and Loscalzo J: Network-based approach
to prediction and population-based validation of in silico drug
repurposing. Nat Commun. 9:26912018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Csardi G and Nepusz T: The igraph software
package for complex network 31. research. Inter Journal, Complex
Systems 1695. 1–9. 2006.
|
|
29
|
Collado-Torres L, Nellore A, Kammers K,
Ellis SE, Taub MA, Hansen KD, Jaffe AE, Langmead B and Leek JT:
Reproducible RNA-seq analysis using recount2. Nat Biotechnol.
35:319–321. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sing T, Sander O, Beerenwinkel N and
Lengauer T: ROCR: Visualizing classifier performance in R.
Bioinformatics. 21:3940–3941. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Langfelder P and Horvath S: Fast R
Functions for robust correlations and hierarchical clustering. J
Stat Softw. 46:1–17. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lima D, Inaba J, Clarindo Lopes L, Calaça
GN, Los Weinert P, Lenzi Fogaça R, Ferreira de Moura J, Magalhães
Alvarenga L, Cavalcante de Figueiredo B, Wohnrath K and Andrade
Pessôa C: Label-free impedimetric immunosensor based on arginine-
functionalized gold nanoparticles for detection of DHEAS, a
biomarker of pediatric adrenocortical carcinoma. Biosens
Bioelectron. 133:86–93. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mohan DR, Lerario AM, Else T, Mukherjee B,
Almeida MQ, Vinco M, Rege J, Mariani BMP, Zerbini MCN, Mendonca BB,
et al: Targeted assessment of G0S2 methylation identifies a rapidly
recurrent, routinely fatal molecular subtype of adrenocortical
carcinoma. Clin Cancer Res. 125:3276–3288. 2019. View Article : Google Scholar
|
|
35
|
Ishida Y, Agata Y, Shibahara K and Honjo
T: Induced expression of PD-1, a novel member of the immunoglobulin
gene superfamily, upon programmed cell death. EMBO J. 11:3887–3895.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ascierto PA, Capone M, Grimaldi AM,
Mallardo D, Simeone E, Madonna G, Roder H, Meyer K, Asmellash S,
Oliveira C, et al: Proteomic test for anti-PD-1 checkpoint blockade
treatment of metastatic melanoma with and without BRAF mutations. J
Immunother Cancer. 7:912019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu X, Hu AX, Zhao JL and Chen FL:
Identification of key gene modules in human osteosarcoma by
co-expression analysis weighted gene co-expression network analysis
(WGCNA). J Cell Biochem. 118:3953–3959. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Grubbs E and Lee JE: Limited prognostic
value of the 2004 International Union Against Cancer staging
classification for adrenocortical carcinoma: Proposal for a revised
TNM classification. Cancer. 115:58482009. View Article : Google Scholar
|
|
39
|
Libe R: Adrenocortical carcinoma (ACC):
Diagnosis, prognosis, and treatment. Front Cell Dev Biol. 3:452015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Petru E, Huber C, Sampl E and Haas J:
Comparison of primary tumor size in stage I and III epithelial
ovarian cancer. Anticancer Res. 38:6507–6511. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sylvestre E, Bouzille G, Breton M, Cuggia
M and Campillo-Gimenez B: Retrieving the vital status of patients
with cancer using online obituaries. Stud Health Technol Inform.
247:571–575. 2018.PubMed/NCBI
|
|
42
|
Roseweir AK, Kong CY, Park JH, Bennett L,
Powell AGMT, Quinn J, van Wyk HC, Horgan PG, McMillan DC, Edwards J
and Roxburgh CS: A novel tumor-based epithelial-to-mesenchymal
transition score that associates with prognosis and metastasis in
patients with Stage II/III colorectal cancer. Int J Cancer.
144:150–159. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Palm MM, Elemans M and Beltman JB:
Heritable tumor cell division rate heterogeneity induces clonal
dominance. PLoS Comput Biol. 14:e10059542018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen G, Kong J, Tucker-Burden C, Anand M,
Rong Y, Rahman F, Moreno CS, Van Meir EG, Hadjipanayis CG and Brat
DJ: Human Brat ortholog TRIM3 is a tumor suppressor that regulates
asymmetric cell division in glioblastoma. Cancer Res. 74:4536–4548.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qian W, Wang J, Roginskaya V, McDermott
LA, Edwards RP, Stolz DB, Llambi F, Green DR and Van Houten B:
Novel combination of mitochondrial division inhibitor 1 (mdivi-1)
and platinum agents produces synergistic pro-apoptotic effect in
drug resistant tumor cells. Oncotarget. 5:4180–4194. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Noël G, Langouo Fontsa M and Willard-Gallo
K: The impact of tumor cell metabolism on T cell-mediated immune
responses and immuno-metabolic biomarkers in cancer. Semin Cancer
Biol. 52:66–74. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Herrero-Ruiz J, Mora-Santos M, Giráldez S,
Sáez C, Japón MA, Tortolero M and Romero F: βTrCP controls the
lysosome-mediated degradation of CDK1, whose accumulation
correlates with tumor malignancy. Oncotarget. 5:7563–7574. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dykes SS, Gao C, Songock WK, Bigelow RL,
Woude GV, Bodily JM and Cardelli JA: Zinc finger E-box binding
homeobox-1 (Zeb1) drives anterograde lysosome trafficking and tumor
cell invasion via upregulation of Na+/H+ Exchanger-1 (NHE1). Mol
Carcinog. 56:722–734. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ravindran Menon D, Luo Y, Arcaroli JJ, Liu
S, KrishnanKutty LN, Osborne DG, Li Y, Samson JM, Bagby S, Tan AC,
et al: CDK1 interacts with Sox2 and promotes tumor initiation in
human melanoma. Cancer Res. 78:6561–6574. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Warfel NA, Dolloff NG, Dicker DT, Malysz J
and El-Deiry WS: CDK1 stabilizes HIF-1α via direct phosphorylation
of Ser668 to promote tumor growth. Cell Cycle. 12:3689–3701. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zeng Y, Stauffer S, Zhou J, Chen X, Chen Y
and Dong J: Cyclin-dependent kinase 1 (CDK1)-mediated mitotic
phosphorylation of the transcriptional co-repressor Vgll4 inhibits
its tumor-suppressing activity. J Biol Chem. 292:15028–15038. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Xiao H, Xu D, Chen P, Zeng G, Wang X and
Zhang X: Identification of five genes as a potential biomarker for
predicting progress and prognosis in adrenocortical carcinoma. J
Cancer. 9:4484–4495. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Eichner R, Fernández-Sáiz V, Targosz BS
and Bassermann F: Cross talk networks of mammalian target of
rapamycin signaling with the ubiquitin proteasome system and their
clinical implications in multiple myeloma. Int Rev Cell Mol Biol.
343:219–297. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hao S, Li S, Wang J, Zhao L, Yan Y, Cao Q,
Wu T, Liu L and Wang C: Transcriptome analysis of
phycocyanin-mediated inhibitory functions on non-small cell lung
cancer A549 cell growth. Mar Drugs. 16(pii): E5112018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tang Y, Geng Y, Luo J, Shen W, Zhu W, Meng
C, Li M, Zhou X, Zhang S and Cao J: Downregulation of ubiquitin
inhibits the proliferation and radioresistance of non-small cell
lung cancer cells in vitro and in vivo. Sci Rep. 5:94762015.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Xia J, Kong L, Zhou LJ, Wu SZ, Yao LJ, He
C, He CY and Peng HJ: Genome-wide bimolecular fluorescence
complementation-based proteomic analysis of Toxoplasma gondii
ROP18's human interactome shows its key role in regulation of cell
immunity and apoptosis. Front Immunol. 9:612018. View Article : Google Scholar : PubMed/NCBI
|
